DIFFERENTIAL INACTIVATION OF MAMMALIAN AND ESCHERICHIA-COLI O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASES BY O-6-BENZYLGUANINE

被引:50
作者
ELDER, RH
MARGISON, GP
RAFFERTY, JA
机构
[1] CRC Department of Carcinogenesis, Paterson Institute Cancer Research, Christie Hospital (NHS) Trust, Manchester M20 9BX, Wilmslow Road
关键词
D O I
10.1042/bj2980231
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The action of O-6-benzylguanine (O-6-BzlG) on recombinant mammalian and Escherichia coli O-6-alkylguanine-DNA alkyltransferases (ATase; EC2.1.1.63; methylated-DNA-protein-cysteine methyltransferase) was compared by preincubation of these proteins with the base, followed by measurement of residual ATase activity using [H-3]methylated substrate DNA. All of the mammalian proteins examined were inactivated by O-6-BzlG (Chinese hamster: I-40, 0.04 mu M; human and rat: I-40, 0.06 mu M); however, the murine ATase was substantially more resistant requiring 4-5 fold higher concentrations of O-6-BzlG to achieve the same levels of inactivation (I-40, 0.28 mu M). A similar differential inactivation was seen with human and murine ATases when extracts of 3T6 (murine) cells and Raji (human) cells were compared. Of the two E. coli ATase proteins, only the ogt-encoded protein was inactivated, but approximately 400 times more O-6-BzlG was required to achieve a level of inactivation similar to that seen with the human protein (I-40, 24.8 mu M). When O-6-BzlG was present in an oligonucleotide, the differential effect on the murine, human and ogt-encoded ATases was not seen and only the ada-encoded ATase remained refractory under the conditions used.
引用
收藏
页码:231 / 235
页数:5
相关论文
共 27 条
  • [1] DEPLETION OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE CORRELATES WITH POTENTIATION OF TEMOZOLOMIDE AND CCNU TOXICITY IN HUMAN TUMOR-CELLS
    BAER, JC
    FREEMAN, AA
    NEWLANDS, ES
    WATSON, AJ
    RAFFERTY, JA
    MARGISON, GP
    [J]. BRITISH JOURNAL OF CANCER, 1993, 67 (06) : 1299 - 1302
  • [2] EXPRESSION IN MAMMALIAN-CELLS OF A TRUNCATED ESCHERICHIA-COLI GENE CODING FOR O-6-ALKYLGUANINE ALKYLTRANSFERASE REDUCES THE TOXIC EFFECTS OF ALKYLATING-AGENTS
    BRENNAND, J
    MARGISON, GP
    [J]. CARCINOGENESIS, 1986, 7 (12) : 2081 - 2084
  • [3] IMPORTANCE OF THE DNA-REPAIR ENZYME O-6-ALKYL GUANINE ALKYLTRANSFERASE (AT) IN CANCER-CHEMOTHERAPY
    DINCALCI, M
    CITTI, L
    TAVERNA, P
    CATAPANO, CV
    [J]. CANCER TREATMENT REVIEWS, 1988, 15 (04) : 279 - 292
  • [4] DOLAN ME, 1991, CANCER RES, V51, P3367
  • [5] MODULATION OF MAMMALIAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE INVIVO BY O-6-BENZYLGUANINE AND ITS EFFECT ON THE SENSITIVITY OF A HUMAN GLIOMA TUMOR TO 1-(2-CHLOROETHYL)-3-(4-METHYLCYCLOHEXYL)-1-NITROSOUREA
    DOLAN, ME
    STINE, L
    MITCHELL, RB
    MOSCHEL, RC
    PEGG, AE
    [J]. CANCER COMMUNICATIONS, 1990, 2 (11): : 371 - 377
  • [6] DEPLETION OF MAMMALIAN OXYGEN-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE ACTIVITY BY OXYGEN-6-BENZYLGUANINE PROVIDES A MEANS TO EVALUATE THE ROLE OF THIS PROTEIN IN PROTECTION AGAINST CARCINOGENIC AND THERAPEUTIC ALKYLATING-AGENTS
    DOLAN, ME
    MOSCHEL, RC
    PEGG, AE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (14) : 5368 - 5372
  • [7] Elder R. H., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P140
  • [8] C-TERMINALLY TRUNCATED HUMAN O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE RETAINS ACTIVITY
    ELDER, RH
    TUMELTY, J
    DOUGLAS, KT
    MARGISON, GP
    RAFFERTY, JA
    [J]. BIOCHEMICAL JOURNAL, 1992, 285 : 707 - 709
  • [9] EXPRESSION OF A HUMAN O-6-ALKYLGUANINE-DNA-ALKYLTRANSFERASE CDNA IN HUMAN-CELLS AND TRANSGENIC MICE
    FAN, CY
    POTTER, PM
    RAFFERTY, J
    WATSON, AJ
    CAWKWELL, L
    SEARLE, PF
    OCONNOR, PJ
    MARGISON, GP
    [J]. NUCLEIC ACIDS RESEARCH, 1990, 18 (19) : 5723 - 5727
  • [10] ENHANCEMENT OF NITROSOUREA ACTIVITY IN MEDULLOBLASTOMA AND GLIOBLASTOMA-MULTIFORME
    FRIEDMAN, HS
    DOLAN, ME
    MOSCHEL, RC
    PEGG, AE
    FELKER, GM
    RICH, J
    BIGNER, DD
    SCHOLD, SC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (24) : 1926 - 1931